Revolution Medicines, Inc. Warrant Liability increased by 85.1% to $34.33M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4476.9%, from $750.00K to $34.33M.
Changes in this value are often driven by market volatility and stock price fluctuations rather than operational performance.
This represents the fair value of outstanding warrants that are classified as liabilities rather than equity. These inst...
Found in companies that have issued warrants as part of financing rounds; common in the biotech sector.
other_warrant_liability_c3b8f1| Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $6.51M | $3.16M | $1.41M | $2.76M | $3.19M | $750.00K | $5.33M | $5.92M | $18.55M | $34.33M |
| QoQ Change | — | — | -51.5% | -55.4% | +96.4% | +15.4% | -76.5% | +610.4% | +11.1% | +213.4% | +85.1% |
| YoY Change | — | — | — | — | — | -51.0% | -76.2% | +278.7% | +114.2% | +481.6% | >999% |